JP2022058814A5 - - Google Patents

Download PDF

Info

Publication number
JP2022058814A5
JP2022058814A5 JP2022014190A JP2022014190A JP2022058814A5 JP 2022058814 A5 JP2022058814 A5 JP 2022058814A5 JP 2022014190 A JP2022014190 A JP 2022014190A JP 2022014190 A JP2022014190 A JP 2022014190A JP 2022058814 A5 JP2022058814 A5 JP 2022058814A5
Authority
JP
Japan
Prior art keywords
waveform
intestinal tract
intestinal
cells
location
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022014190A
Other languages
English (en)
Japanese (ja)
Other versions
JP7143539B2 (ja
JP2022058814A (ja
Filing date
Publication date
Priority claimed from JP2019202441A external-priority patent/JP2020032236A/ja
Application filed filed Critical
Publication of JP2022058814A publication Critical patent/JP2022058814A/ja
Priority to JP2022129621A priority Critical patent/JP7341297B2/ja
Publication of JP2022058814A5 publication Critical patent/JP2022058814A5/ja
Application granted granted Critical
Publication of JP7143539B2 publication Critical patent/JP7143539B2/ja
Priority to JP2023130936A priority patent/JP7788058B2/ja
Priority to JP2025010861A priority patent/JP2025061805A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022014190A 2009-08-03 2022-02-01 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法 Active JP7143539B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022129621A JP7341297B2 (ja) 2009-08-03 2022-08-16 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2023130936A JP7788058B2 (ja) 2009-08-03 2023-08-10 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2025010861A JP2025061805A (ja) 2009-08-03 2025-01-24 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27338909P 2009-08-03 2009-08-03
US61/273,389 2009-08-03
JP2019202441A JP2020032236A (ja) 2009-08-03 2019-11-07 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019202441A Division JP2020032236A (ja) 2009-08-03 2019-11-07 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022129621A Division JP7341297B2 (ja) 2009-08-03 2022-08-16 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法

Publications (3)

Publication Number Publication Date
JP2022058814A JP2022058814A (ja) 2022-04-12
JP2022058814A5 true JP2022058814A5 (enExample) 2022-08-25
JP7143539B2 JP7143539B2 (ja) 2022-09-28

Family

ID=43544631

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2012523704A Active JP5854513B2 (ja) 2009-08-03 2010-08-03 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2014215009A Withdrawn JP2015042285A (ja) 2009-08-03 2014-10-22 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2017000868A Withdrawn JP2017121487A (ja) 2009-08-03 2017-01-06 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2019202441A Pending JP2020032236A (ja) 2009-08-03 2019-11-07 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2022014190A Active JP7143539B2 (ja) 2009-08-03 2022-02-01 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2022129621A Active JP7341297B2 (ja) 2009-08-03 2022-08-16 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2025010861A Pending JP2025061805A (ja) 2009-08-03 2025-01-24 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2012523704A Active JP5854513B2 (ja) 2009-08-03 2010-08-03 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2014215009A Withdrawn JP2015042285A (ja) 2009-08-03 2014-10-22 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2017000868A Withdrawn JP2017121487A (ja) 2009-08-03 2017-01-06 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2019202441A Pending JP2020032236A (ja) 2009-08-03 2019-11-07 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022129621A Active JP7341297B2 (ja) 2009-08-03 2022-08-16 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP2025010861A Pending JP2025061805A (ja) 2009-08-03 2025-01-24 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法

Country Status (6)

Country Link
US (9) US8682440B2 (enExample)
EP (2) EP3466438A1 (enExample)
JP (7) JP5854513B2 (enExample)
CN (2) CN102770151B (enExample)
AU (2) AU2010279575B2 (enExample)
WO (1) WO2011017335A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102770151B (zh) 2009-08-03 2018-07-31 因卡伯实验室有限责任公司 用于刺激肠道内肠促胰岛素产生的吞咽式囊和方法
US8562589B2 (en) 2009-12-24 2013-10-22 Rani Therapeutics, Llc Swallowable drug delivery device and method of delivery
CN103025319B (zh) * 2010-03-10 2015-07-01 因卡伯实验室有限责任公司 用于利用可吞咽式药剂递送装置递送到肠道内腔中的治疗剂制剂
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2013143603A1 (en) * 2012-03-30 2013-10-03 Ethicon Endo-Surgery, Inc. Devices and methods for the treatment of metabolic disorders
US20140051924A1 (en) * 2012-08-16 2014-02-20 Capso Vision, Inc In Vivo Capsule Device with Electrodes
WO2015042558A1 (en) * 2013-09-23 2015-03-26 Board Of Regents, The University Of Texas System Wireless tissue stimulation devices
EP3142645A4 (en) 2014-05-15 2017-12-27 Rani Therapeutics, LLC Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
US10689460B2 (en) 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2016073728A1 (en) * 2014-11-05 2016-05-12 Enterastim, Inc. Conditional gastrointestinal stimulation for improved motility
US20160183878A1 (en) * 2014-12-27 2016-06-30 John C. Weast Technologies for managing device functions of an ingestible computing device
US10500127B2 (en) * 2016-04-18 2019-12-10 Ankon Medical Technologies (Shanghai) Co., Ltd. Vivo device and method of using the same
WO2018026720A1 (en) * 2016-07-31 2018-02-08 Hans Gregersen Autoexpandable devices for obtaining impedance, pressure, and other measurements in the gastrointestinal tract and other organs
EP3296727B1 (en) * 2016-09-19 2019-04-17 Murata Integrated Passive Solutions Electrical stimulation and monitoring device
IL250090B (en) 2017-01-12 2018-10-31 Melcap Systems Ltd A capsule is intended for ingestion by a subject and a system is intended for the digestive system
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
IL301683B2 (en) 2017-05-17 2025-02-01 Massachusetts Inst Technology Self-healing systems and related components and methods
CN108742590A (zh) * 2018-04-08 2018-11-06 南京宽诚科技有限公司 一种胃肠电信号的采集方法、装置、采集设备及存储介质
EP3793667A1 (en) 2018-05-17 2021-03-24 Massachusetts Institute of Technology Systems for electrical stimulation
AU2019277199B2 (en) * 2018-05-31 2024-04-04 Lynne Bilston Systems, devices and methods for the treatment of oral and pharyngeal disorders
CN109498989A (zh) * 2018-12-20 2019-03-22 宁波贝思转化医学研究中心有限公司 一种用于判断胃肠电刺激是否有效的装置及其使用方法
US11771829B2 (en) 2019-02-01 2023-10-03 Massachusetts Institute Of Technology Systems and methods for liquid injection
US11833319B2 (en) * 2019-03-01 2023-12-05 Rani Therapeutics, Llc Propulsive drug delivery from a swallowable device into a patients intestinal tract
US20220293239A1 (en) * 2019-09-24 2022-09-15 Panasonic Intellectual Property Management Co., Ltd. Recipe output method and recipe output system
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components
KR102608853B1 (ko) * 2021-11-15 2023-12-01 재단법인 아산사회복지재단 대사질환 개선용 생체발광 캡슐

Family Cites Families (179)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3788322A (en) * 1972-12-27 1974-01-29 Alza Corp Drug delivery device with means for maintaining device in environment of use
US4249531A (en) 1979-07-05 1981-02-10 Alza Corporation Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
DE2928477C3 (de) * 1979-07-14 1982-04-15 Battelle-Institut E.V., 6000 Frankfurt Vorrichtung zur Freisetzung von Substanzen an definierten Orten des Verdauungstraktes
JPS60129057A (ja) 1983-12-14 1985-07-10 住友化学工業株式会社 針状固形製剤投与針
US4596819A (en) 1984-01-23 1986-06-24 Warner-Lambert Company Modified tripeptides
US4663308A (en) 1984-07-18 1987-05-05 Medical College Of Ohio Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract
FR2597351B1 (fr) * 1986-04-16 1994-03-25 Celsa Composants Electriques Capsule distributrice de drogue implantable et procede et dispositif facilitant son utilisation.
US5137669A (en) 1988-03-02 1992-08-11 Endocon, Inc. Manufacture of partially fused peptide pellet
US5271945A (en) 1988-07-05 1993-12-21 Takeda Chemical Industries, Ltd. Sustained release microcapsule for water soluble drug
JP2691937B2 (ja) * 1988-07-05 1997-12-17 カンテニース,ジョゼ 胃内バルーン
US5474785A (en) * 1990-01-24 1995-12-12 Alza Corporation Delivery system comprising means for controlling internal pressure
US5217449A (en) * 1990-12-11 1993-06-08 Miyarisan Kabushiki Kaisha Medical capsule and apparatus for activating the same
US5279607A (en) 1991-05-30 1994-01-18 The State University Of New York Telemetry capsule and process
EP0607321A1 (en) * 1991-10-10 1994-07-27 Alza Corporation Osmotic drug delivery devices with hydrophobic wall materials
US5318557A (en) 1992-07-13 1994-06-07 Elan Medical Technologies Limited Medication administering device
DK42093D0 (da) 1993-04-07 1993-04-07 Bukh Meditec Administrationsmetode
US5437291A (en) * 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US5652216A (en) 1994-05-26 1997-07-29 Novo Nordisk A/S Pharmaceutical preparation
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US5904935A (en) 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US5750926A (en) * 1995-08-16 1998-05-12 Alfred E. Mann Foundation For Scientific Research Hermetically sealed electrical feedthrough for use with implantable electronic devices
US5620476A (en) * 1995-11-13 1997-04-15 Pacesetter, Inc. Implantable medical device having shielded and filtered feedthrough assembly and methods for making such assembly
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5987358A (en) * 1998-02-17 1999-11-16 Intermedics, Inc. Semiconductor device packaging and method of fabrication
IT1299266B1 (it) 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
US6395273B1 (en) 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
US8700161B2 (en) * 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
DE60035181T2 (de) * 1999-03-05 2008-02-21 Metacure Ltd. Steuerung des blutzuckerspiegels
WO2004112563A2 (en) * 2003-06-20 2004-12-29 Metacure N.V., Gastrointestinal methods and apparatus for use in treating disorders
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
GB9930000D0 (en) 1999-12-21 2000-02-09 Phaeton Research Ltd An ingestible device
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6832114B1 (en) * 2000-11-21 2004-12-14 Advanced Bionics Corporation Systems and methods for modulation of pancreatic endocrine secretion and treatment of diabetes
US6638246B1 (en) * 2000-11-28 2003-10-28 Scimed Life Systems, Inc. Medical device for delivery of a biologically active material to a lumen
KR20030074693A (ko) 2000-12-28 2003-09-19 알투스 바이올로직스 인코포레이티드 전항체 및 이의 단편의 결정과 이의 제조 및 사용 방법
US7069081B2 (en) * 2001-02-08 2006-06-27 Wilson Greatbatch Ltd. One piece header assembly for an implantable medical device
EP2302387A1 (en) 2001-04-10 2011-03-30 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles for insulin-dependent diabetes mellitus
US7787958B2 (en) * 2001-04-13 2010-08-31 Greatbatch Ltd. RFID detection and identification system for implantable medical lead systems
US7160258B2 (en) 2001-06-26 2007-01-09 Entrack, Inc. Capsule and method for treating or diagnosing the intestinal tract
JP4307995B2 (ja) * 2001-07-12 2009-08-05 ギブン イメージング リミテッド 身体の管腔を検査するための装置
US20070162085A1 (en) * 2001-07-23 2007-07-12 Dilorenzo Biomedical, Llc Method, apparatus, surgical technique, and stimulation parameters for autonomic neuromodulation for the treatment of obesity
US20030226155A1 (en) 2001-08-30 2003-12-04 Biorexis Pharmaceutical Corporation Modified transferrin-antibody fusion proteins
JP4643089B2 (ja) 2001-09-27 2011-03-02 オリンパス株式会社 カプセル型医療装置
JP2002186672A (ja) 2001-09-28 2002-07-02 Olympus Optical Co Ltd 医療用カプセル装置
AU2002337803A1 (en) 2001-10-03 2003-04-14 Glaxo Group Limited Sustained release pharmaceutical compositions
US6656155B2 (en) 2001-12-17 2003-12-02 Scimed Life Systems, Inc. Catheter for endoluminal delivery of therapeutic agents that minimizes loss of therapeutic
FR2835730B1 (fr) 2002-02-11 2004-12-10 C T M Ct De Transfert Des Micr Dispositif pour la delivrance de substances et le prelevement intracorporel
US20030186892A1 (en) 2002-03-28 2003-10-02 Rajneesh Taneja Enhancement of endogenous gonadotropin production
US8062573B2 (en) 2002-09-16 2011-11-22 Theraject, Inc. Solid micro-perforators and methods of use
US7118531B2 (en) 2002-09-24 2006-10-10 The Johns Hopkins University Ingestible medical payload carrying capsule with wireless communication
AU2002951740A0 (en) * 2002-09-30 2002-10-17 Cochlear Limited Feedthrough for electrical connectors
EP1590034B1 (en) 2002-10-07 2014-05-14 Biovalve Technologies, Inc. Microneedle array patch
US20040093039A1 (en) * 2002-10-25 2004-05-13 Raphael Schumert Gastrointestinal pacemaker
AU2003288516A1 (en) 2002-12-26 2004-07-22 Given Imaging Ltd. Immobilizable in vivo sensing device
US20040143221A1 (en) 2002-12-27 2004-07-22 Shadduck John H. Biomedical implant for sustained agent release
US20040267240A1 (en) * 2003-01-29 2004-12-30 Yossi Gross Active drug delivery in the gastrointestinal tract
RU2334506C2 (ru) 2003-01-29 2008-09-27 И-Пилл Фарма Лтд. Активная доставка лекарственного средства в желудочно-кишечном тракте
US20050058701A1 (en) 2003-01-29 2005-03-17 Yossi Gross Active drug delivery in the gastrointestinal tract
JP2005021677A (ja) 2003-06-10 2005-01-27 Medorekkusu:Kk 経皮投薬用パッドベース、及び注射針
JP2007525472A (ja) 2003-07-04 2007-09-06 ニコメド ダンマーク エイピーエス 経口使用のための副甲状腺ホルモン(pth)含有医薬組成物
US20070060971A1 (en) * 2003-07-21 2007-03-15 Ofer Glasberg Hepatic device for treatment or glucose detection
US7276477B2 (en) 2003-08-01 2007-10-02 Amgen Inc. Crystals of etanercept and methods of making thereof
US20050038415A1 (en) * 2003-08-06 2005-02-17 Rohr William L. Method and apparatus for the treatment of obesity
US8353861B2 (en) 2003-09-18 2013-01-15 Texmac, Inc. Applicator for applying functional substances into human skin
WO2005032511A2 (en) 2003-09-30 2005-04-14 Spherics, Inc. Nanoparticulate therapeutic biologically active agents
JP4733918B2 (ja) 2003-10-01 2011-07-27 オリンパス株式会社 カプセル投薬システム
US20050124875A1 (en) 2003-10-01 2005-06-09 Olympus Corporation Vivo observation device
BRPI0415765A (pt) 2003-10-24 2006-12-26 Medtronic Inc técnicas para tratar desordens neurológicas pela atenuação da produção de mediadores pró-inflamatórios
JP4094543B2 (ja) * 2003-12-26 2008-06-04 オリンパス株式会社 カプセル型医療装置システム
EP1690490B1 (en) * 2003-11-11 2012-04-18 Olympus Corporation Capsule type medical device system
JP2005143560A (ja) * 2003-11-11 2005-06-09 Olympus Corp カプセル型医療装置
WO2005051444A2 (en) 2003-11-20 2005-06-09 Angiotech International Ag Soft tissue implants and anti-scarring agents
US8585771B2 (en) 2004-02-26 2013-11-19 Endosphere, Inc. Methods and devices to curb appetite and/or to reduce food intake
MY162179A (en) 2004-04-01 2017-05-31 Elan Pharm Inc Steroid sparing agents and methods of using same
US8000784B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling device
DE102004026615A1 (de) 2004-06-01 2005-12-29 Siemens Ag Vorrichtung und Verfahren zur Freisetzung eines in das Körperinnere eines Patienten geführten therapeutischen Mittels
JP2006000307A (ja) 2004-06-16 2006-01-05 Pentax Corp 酸素発生装置を有するカプセル型医療用具
US20060153894A1 (en) 2004-06-30 2006-07-13 Ragae Ghabrial Multi-compartment delivery system
CA2573512C (en) 2004-07-12 2014-09-23 Emisphere Technologies, Inc. Compositions for delivering peptide yy and pyy agonists
EP1796529B1 (en) * 2004-09-08 2016-02-03 Olympus Corporation Capsule type medical device
US20060063719A1 (en) 2004-09-21 2006-03-23 Point Therapeutics, Inc. Methods for treating diabetes
US20070265598A1 (en) 2004-09-30 2007-11-15 Duocure, Inc. Device and Method for Treating Weight Disorders
EP1827387A2 (en) 2004-12-14 2007-09-05 E-Pill Pharma Ltd. Prolonged transit time of permeability-enhancing drug eluting pill
WO2006074051A2 (en) 2004-12-30 2006-07-13 Diakine Therapeutics, Inc. PHARMACEUTICAL COMPOSITIONS AND METHODS FOR RESTORING β-CELL MASS AND FUNCTION
US7556826B2 (en) 2005-01-04 2009-07-07 Gp Medical, Inc. Nanoparticles for protein drug delivery
EP1841490A2 (en) * 2005-01-18 2007-10-10 Koninklijke Philips Electronics N.V. Electronically controlled capsule
US7785291B2 (en) * 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
CN2860501Y (zh) 2005-03-10 2007-01-24 李华 一次性注射器
AU2006248571A1 (en) * 2005-05-19 2006-11-23 E-Pill Pharma, Ltd Ingestible device for nitric oxide production in tissue
CN101184523B (zh) 2005-05-27 2011-04-13 奥林巴斯株式会社 被检体内导入装置
US20070016262A1 (en) * 2005-07-13 2007-01-18 Betastim, Ltd. Gi and pancreatic device for treating obesity and diabetes
US8021384B2 (en) * 2005-07-26 2011-09-20 Ram Weiss Extending intrabody capsule
AU2006273679B2 (en) 2005-07-26 2012-05-03 Menachem P. Weiss Extending intrabody capsule
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
HRP20150186T1 (hr) 2005-08-19 2015-05-22 Amylin Pharmaceuticals, Llc. Eksendin za lijeäśenje dijabetesa i smanjenje tjelesne težine
CA2623772A1 (en) * 2005-09-19 2007-03-29 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Modulation of glucocorticoid receptor expression
US7957796B2 (en) * 2005-10-28 2011-06-07 Cyberonics, Inc. Using physiological sensor data with an implantable medical device
JP4402648B2 (ja) * 2005-12-16 2010-01-20 オリンパス株式会社 被検体内導入装置
GB0603252D0 (en) 2006-02-17 2006-03-29 Axcess Ltd Dissolution aids for oral peptide delivery
WO2007100770A2 (en) 2006-02-28 2007-09-07 Elan Pharmaceuticals, Inc. Methods of treating inflammatory and autoimmune diseases with natalizumab
US20060229529A1 (en) 2006-03-30 2006-10-12 Wright Robert C System, apparatus, and method for marking orientation of a tissue sample
US7818876B2 (en) * 2006-04-25 2010-10-26 Gregg Jorgen Suaning Method for fabrication of hermetic electrical conductor feedthroughs
CA2652569C (en) 2006-05-18 2015-12-22 Tulip Medical Ltd. Bioerodible self-deployable intragastric and non-gastric implants
US20070288033A1 (en) * 2006-06-09 2007-12-13 Allergan, Inc. Intragastric balloon retrieval mechanisms
KR20090101893A (ko) 2006-10-27 2009-09-29 애보트 바이오테크놀로지 리미티드 결정형 항-hTNF알파 항체
RU2009120512A (ru) * 2006-10-31 2010-12-10 Конинклейке Филипс Электроникс Н.В. (Nl) Конструкция глотаемого дозирующего устройства с множеством форсунок для выпуска лекарств в желудочно-кишечный тракт
US20080214919A1 (en) 2006-12-26 2008-09-04 Lifescan, Inc. System and method for implementation of glycemic control protocols
US9037244B2 (en) 2007-02-13 2015-05-19 Virender K. Sharma Method and apparatus for electrical stimulation of the pancreatico-biliary system
US8160708B2 (en) * 2007-04-11 2012-04-17 Pacesetter, Inc. Capacitor-integrated feedthrough assembly with improved grounding for an implantable medical device
US20080260820A1 (en) 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
CN104000779A (zh) 2007-04-23 2014-08-27 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
US9364666B2 (en) 2007-05-07 2016-06-14 Transtimulation Research, Inc. Method of using a gastrointestinal stimulator device for digestive and eating disorders
US7925351B2 (en) * 2007-06-13 2011-04-12 Betastim, Ltd. Gastrointestinal device for treating obesity and diabetes
US20090030743A1 (en) 2007-07-24 2009-01-29 Las Vegas Central Reservation Corp. Intelligent Hotel Reservation System and Method
US7960336B2 (en) 2007-08-03 2011-06-14 Pharmain Corporation Composition for long-acting peptide analogs
US7930033B2 (en) 2007-08-17 2011-04-19 Jianfeng Chen Appendicular and rectal stimulator device for digestive and eating disorders
EP2196131A4 (en) 2007-09-26 2012-12-05 Olympus Medical Systems Corp INTRODUCTION SYSTEM IN A SUBJECT
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
EP2262442B1 (en) * 2008-04-11 2015-03-25 BAL Seal Engineering Connector cartridge stack for electrical transmission
WO2009129465A2 (en) 2008-04-17 2009-10-22 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of xbp-1 gene
JP2011519915A (ja) * 2008-05-05 2011-07-14 オラムド エルティーディー. エクセナチドの経口投与用の方法および組成物
DE602009001050D1 (de) 2008-06-04 2011-05-26 Olympus Medical Systems Corp Kapselförmige medizinische Vorrichtung
US20090317372A1 (en) 2008-06-20 2009-12-24 Zoltan Kiss Small molecules for the reduction of high blood glucose level
US8287902B2 (en) * 2008-07-23 2012-10-16 Rainbow Medical Ltd. Enhanced-diffusion capsule
EP2334374A4 (en) * 2008-08-26 2011-12-28 Janssen Biotech Inc STIMULATING THE RELEASE OF A SATIETY HORMONE
US8948870B2 (en) 2008-09-09 2015-02-03 Incube Labs, Llc Energy harvesting mechanism
MX2011002794A (es) 2008-09-25 2011-04-05 Hoffmann La Roche Indazol 2,3-sustituido o 4,5,6,7-tetrahidro-indazol como moduladores fxr contra dislipidemia y enfermedades relacionadas.
US8535260B2 (en) 2008-10-15 2013-09-17 Dtherapeutics, Llc Devices, systems, and methods for localized drug delivery
US9072583B2 (en) * 2008-10-16 2015-07-07 Obalon Therapeutics, Inc. Intragastric volume-occupying device and method for fabricating same
WO2010045656A2 (en) 2008-10-17 2010-04-22 Nectid, Inc. Novel sglt2 inhibitor dosage forms
WO2010055796A1 (ja) 2008-11-13 2010-05-20 オリンパスメディカルシステムズ株式会社 カプセル型医療装置
US20100131043A1 (en) 2008-11-26 2010-05-27 Casas Jesus W Endoluminal Implants For Bioactive Material Delivery
WO2010093834A2 (en) 2009-02-12 2010-08-19 Incube Labs, Llc Skin penetrating device and method for subcutaneous solid drug delivery
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CN102770151B (zh) 2009-08-03 2018-07-31 因卡伯实验室有限责任公司 用于刺激肠道内肠促胰岛素产生的吞咽式囊和方法
US8834423B2 (en) 2009-10-23 2014-09-16 University of Pittsburgh—of the Commonwealth System of Higher Education Dissolvable microneedle arrays for transdermal delivery to human skin
AU2010336330B2 (en) 2009-12-24 2016-04-28 Rani Therapeutics, Llc Swallowable drug delivery device and methods of drug delivery
US8562589B2 (en) 2009-12-24 2013-10-22 Rani Therapeutics, Llc Swallowable drug delivery device and method of delivery
CN103025319B (zh) 2010-03-10 2015-07-01 因卡伯实验室有限责任公司 用于利用可吞咽式药剂递送装置递送到肠道内腔中的治疗剂制剂
US20110295337A1 (en) 2010-05-26 2011-12-01 Albrecht Thomas E Systems and Methods For Regulating Metabolic Hormone Producing Tissue
US8876761B2 (en) 2010-05-26 2014-11-04 Ethicon Endo-Surgery, Inc. Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods
US8603023B2 (en) 2010-05-26 2013-12-10 Ethicon Endo-Surgery, Inc. Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods
US20110295178A1 (en) 2010-05-26 2011-12-01 Albrecht Thomas E Intestinal Brake Inducing Intraluminal Therapeutic Substance Eluting Devices and Methods
WO2012035559A2 (en) 2010-09-17 2012-03-22 Panacea Biotec Ltd Sustained release pharmaceutical compositions comprising pregabalin
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
PL2726091T3 (pl) 2011-06-29 2020-08-10 Rani Therapeutics, Llc Preparaty lecznicze dostarczane do kanału przewodu jelitowego za pomocą połykalnego urządzenia dostarczającego lek
PL3653223T3 (pl) 2011-06-29 2021-12-20 Rani Therapeutics, Llc Urządzenie do doustnego dostarczania związków leczniczych
WO2013143599A1 (en) 2012-03-30 2013-10-03 Ethicon Endo-Surgery, Inc. Devices and methods for the treatment of metabolic disorders.
WO2013143600A1 (en) 2012-03-30 2013-10-03 Ethicon Endo-Surgery, Inc. Devices and methods for the treatment of metabolic disorders.
WO2013143609A1 (en) 2012-03-30 2013-10-03 Ethicon Endo-Surgery, Inc. Devices and methods for the treatment of metabolic disorders
WO2013143603A1 (en) 2012-03-30 2013-10-03 Ethicon Endo-Surgery, Inc. Devices and methods for the treatment of metabolic disorders
WO2013143612A1 (en) 2012-03-30 2013-10-03 Ethicon Endo-Surgery, Inc. Devices and methods for the treatment of metabolic disorders
WO2013165964A1 (en) 2012-04-30 2013-11-07 Carnegie Mellon University An ingestible, electrical device for stimulating tissues in a gastrointestinal tract of an organism
US8755888B2 (en) 2012-10-17 2014-06-17 Melcap Systems Ltd. Gastrointestinal system
US9168000B2 (en) 2013-03-13 2015-10-27 Ethicon Endo-Surgery, Inc. Meal detection devices and methods
CA2901923C (en) 2013-03-15 2021-12-07 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US11116658B2 (en) 2015-06-28 2021-09-14 Oberon Sciences Ilan Ltd. Devices for gastrointestinal stimulation and uses thereof
AU2016287843B2 (en) 2015-07-02 2021-06-17 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
CN105997466B (zh) 2016-06-16 2018-01-26 中南民族大学 智能型振动电子胶囊
WO2018026720A1 (en) 2016-07-31 2018-02-08 Hans Gregersen Autoexpandable devices for obtaining impedance, pressure, and other measurements in the gastrointestinal tract and other organs
IL250090B (en) 2017-01-12 2018-10-31 Melcap Systems Ltd A capsule is intended for ingestion by a subject and a system is intended for the digestive system
WO2018146675A1 (en) 2017-02-07 2018-08-16 Yaron Ilan Closed loop organ stimulation
EP3793667A1 (en) 2018-05-17 2021-03-24 Massachusetts Institute of Technology Systems for electrical stimulation
US20230285227A1 (en) 2022-03-14 2023-09-14 Massachusetts Institute Of Technology Ingestible capsules

Similar Documents

Publication Publication Date Title
JP2022058814A5 (enExample)
JP7143539B2 (ja) 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
JP7608167B2 (ja) 換気装置および患者を換気する方法
JP2013501060A5 (enExample)
JP2020022781A5 (enExample)
JP2006517827A5 (enExample)
JP2017500986A5 (enExample)
JP2710864B2 (ja) 経皮的に配置される電気による腸のペースメーカー
WO2008005270A8 (en) Local and non-local sensing for cardiac pacing
JP2006528019A5 (enExample)
JP2009535188A5 (enExample)
US20150343211A1 (en) Gi tract stimulation devices and methods
EP1690565A3 (en) Monitoring physiological signals during external electrical stimulation
JP2012200558A (ja) 嚥下誘発装置
CN208823794U (zh) 一种植入式胃刺激器
US20250001193A1 (en) Stimulation arrangement and method of identifying a position of a field generator
CN102892461B (zh) 口部粘膜电穿孔装置及其用途
JP7788058B2 (ja) 腸管内でインクレチン生産を刺激するための嚥下可能カプセルおよび方法
CN111407307A (zh) 肠蠕动电刺激按摩装置及电刺激按摩方法
RU2002133162A (ru) Способ восстановления моторно-эвакуаторной функции желудочно-кишечного тракта и устройство для его осуществления
CN206304225U (zh) 植入消化道黏膜下的自动感知顺序电起搏装置